However, the traditional serum tumor biomarkers for breast cancer, such as carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), and CA15–3, show low sensitivity and are frequently utilized for follow-up monitoring instead of early diagnosis [158]. Here, CEACAM5 is linked to breast carcinoma.